Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Daily Voice.
Press releases published on May 27, 2025

Innovation in Motion: Soroka Medical Center Earns Top 2025 Urban Planning Prize
BE'ER SHEVA, ISRAEL, May 27, 2025 /EINPresswire.com/ -- The borders of municipal hospitals are often marked by perimeter fences designed to ensure safety and control for patients and staff. Yet these boundaries also physically and symbolically separate …

Enlight Announces Conference Call to Discuss “Enlight and the IRA Transition” on May 29, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, "the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, announces that it will host a conference call to discuss “Enlight and the IRA …

SONSIEL and The DAISY Foundation Celebrate Nurse Innovation at THInC with Inaugural DAISY Awards
BOSTON, MA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In a landmark moment for nursing innovation and recognition, the Society of Nurse Scientists, Innovators, Entrepreneurs, and Leaders (SONSIEL) and The DAISY Foundation proudly presented the …

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collaboration builds on …

Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives
RA'ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneering company in advanced respiratory support and diagnostic systems, today announced an evolution in its executive …

Nexxen Announced as a Preliminary Addition to the Russell 3000 Index
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has been named a …

Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions
PETAH TIKVA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Commercial Division received over $25 …